NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 9, 2026
NexImmune Market Cap
NexImmune has a market cap or net worth of $279 as of February 13, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
279.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 279.00, a decrease of -100.00%. That is a compound annual growth rate of -94.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 279.00 | 27,800.00% |
| Dec 31, 2025 | 1.00 | -100.00% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Alzex Neuropharma | 452.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Predictive Technology Group | 317.00 |
| Spencer Pharmaceutical | 271.00 |
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |